A. Jasselin-Hinschberger, C. Comoy, Y. Fort
FULL PAPER
7-Bromo-2-chloro-3-(trimethylsilyl)furo[3,2-b]pyridine (3b): The ge-
neral procedure was employed by using CBr4 (1.06 g, 3.2 mmol,
4.0 equiv.) as the electrophile. Purification by centrifugal thin-layer
chromatography (cyclohexane) afforded compound 3b (205 mg,
84%) as an orange solid; m.p. 42–45 °C. 1H NMR (CDCl3): δ =
0.46 (s, 9 H), 7.33 (d, J = 5.1 Hz, 1 H), 8.29 (d, J = 5.1 Hz, 1
H) ppm. 13C NMR (CDCl3): δ = –0.8 (3 C), 112.4, 122.3, 122.6,
146.3, 146.5, 150.3, 153.1 ppm. MS (EI): m/z (%) = 305 (26) [M +
2]+, 303 (19) [M]+, 290 (100), 288 (78), 268 (15). HRMS (ESI):
calcd. for C10H12BrClNOSi [M + H]+ 303.9555; found 303.9544.
Experimental Section
1
General Methods: The H and 13C NMR spectroscopic data were
recorded at 250 MHz for 1H NMR and 63 MHz for 13C NMR,
and CDCl3 was used as solvent with TMS as the internal standard
1
(for H NMR). HRMS spectra were recorded on a micrOTOF-Q
spectrometer. MS data were recorded on a GC–MS-QP2010 spec-
trometer. Melting temperatures were recorded with a thermostatic
oil bath device. All one-pot reactions were carried out in a two-
necked Schlenk flask that was connected to a vacuum line. All rea-
gents were commercially available and purified by distillation when
necessary. nBuLi was used as a commercial 1.6 m solution in hex-
anes (always titrated prior to use). Hexanes and THF were distilled
and stored over sodium wire prior to use. Purifications by centrifu-
gal thin-layer chromatography were performed on silica gel (silica
gel 60 PF254 that contained gypsum).
2,7-Dichloro-3-(trimethylsilyl)furo[3,2-b]pyridine (3c): The general
procedure was employed by using hexachloroethane (757 mg,
3.2 mmol, 4.0 equiv.) as the electrophile. Purification by centrifugal
thin-layer chromatography (cyclohexane/AcOEt, from 10:0 to 95:5)
afforded compound 3c (177 mg, 85%) as a white solid; m.p. 48–
1
50 °C. H NMR (CDCl3): δ = 0.46 (s, 9 H), 7.19 (d, J = 5.3 Hz, 1
H), 8.39 (d, J = 5.3 Hz, 1 H) ppm. 13C NMR (CDCl3): δ = –0.8 (3
C), 112.4, 119.4, 124.8, 144.5, 146.3, 150.5, 153.7 ppm. MS (EI):
m/z (%) = 259 (25) [M]+, 244 (100), 224 (15), 73 (35). HRMS (ESI):
calcd. for C10H12Cl2NOSi [M + H]+ 260.0060; found 260.0042.
General Procedure for the Preparation of LiTMP Base: To a solu-
tion of 2,2,6,6-tetramethylpiperidine (542 mg, 3.84 mmol,
1.0 equiv.) in anhydrous tetrahydrofuran (10 mL) at –20 °C was
added dropwise nBuLi (1.6 m in hexanes, 2.4 mL, 3.84 mmol,
1.0 equiv.) under argon. After 30 min at 0 °C, the LiTMP base
(0.31 m solution) was ready to be used. The sequential functionali-
zation at the C-3, C-7, and C-6 positions of 2-chlorofuro[3,2-b]-
pyridine (1) are described in the literature.[7]
1-(2-Chloro-3-(trimethylsilyl)furo[3,2-b]pyridin-7-yl)-1-phenylmeth-
anol (3d): The general procedure was employed by using benzalde-
hyde (339 mg, 3.2 mmol, 4.0 equiv.) as the electrophile. Purification
by centrifugal thin-layer chromatography (cyclohexane/AcOEt,
from 10:0 to 95:5) afforded compound 3d (212 mg, 80%) as a yel-
General Procedure for the Evaporation Step: Dry THF (10.0 mL)
was added under argon. The reaction system was gradually put
under vacuum to evaporate approximately half of the solvent, and
the reaction mixture was then placed again under argon. This pro-
cedure (i.e., the addition of dry THF and evaporation of half of
the solvent) was repeated (2ϫ). A sample of the reaction mixture
was analyzed by GC–MS to ensure that this method did not lead
to the degradation of the products.
1
low gummy substance. H NMR (CDCl3): δ = 0.44 (s, 9 H), 2.65
(br. s, 1 H), 6.25 (s, 1 H), 7.29–7.37 (m, 4 H), 7.46–7.49 (m, 2 H),
8.48 (d, J = 5.1 Hz, 1 H) ppm. 13C NMR (CDCl3): δ = –0.7 (3 C),
70.6, 115.5, 126.6 (2 C), 128.3, 128.8 (2 C), 134.4, 141.6, 144.5,
146.3, 148.1, 149.6, 152.4 ppm. MS (EI): m/z (%) = 331 (53) [M]+,
316 (100), 296 (58). HRMS (ESI): calcd. for C17H19ClNO2Si [M +
H]+ 332.0868; found 332.0861.
2-Chloro-7-(tri-n-butylstannyl)-3-(trimethylsilyl)furo[3,2-b]pyridine
(3e): The general procedure was employed by using Bu3SnCl
(1.04 g, 3.2 mmol, 4.0 equiv.) as the electrophile. Purification by
centrifugal thin-layer chromatography (cyclohexane/AcOEt, from
10:0 to 98:2) afforded compound 3e (342 mg, 83%) as a colorless
General Procedure for the One-pot Synthesis of Derivatives 3a–3g:
To
a
solution of 2-chlorofuro[3,2-b]pyridine (1)[6b] (123 mg,
0.80 mmol, 1.0 equiv.) in THF (10 mL) was added dropwise nBuLi
(0.6 mL, 0.96 mmol, 1.2 equiv.) at –20 °C under argon. After the
reaction mixture was stirred at –20 °C for 1 h, chlorotrimethylsilane
(174 mg, 1.6 mmol, 2.0 equiv.) was added in THF (5 mL) at –20 °C.
The temperature was then warmed to 20 °C over 20 min. The mix-
ture was stirred at 20 °C for 40 min, and then the evaporation step
was performed as described in the general procedure above. The
temperature was cooled to –20 °C, and a solution of LiTMP
(10.3 mL, 3.2 mmol, 4.0 equiv.) was quickly added under argon.
The resulting mixture was stirred at –20 °C for 1 h, and then the
appropriate electrophile (3.2 mmol, 4.0 equiv.) was added in THF
(5 mL). The temperature was then warmed to 20 °C over 20 min.
After the reaction was stirred at 20 °C for 40 min, the hydrolysis
step was performed by adding H2O (10 mL) at 20 °C. The aqueous
layer was then extracted with AcOEt (2ϫ 10 mL). The combined
organic layers were dried with MgSO4 and filtered, and the solvent
was evaporated. The crude product was purified by centrifugal
thin-layer chromatography.
1
liquid. H NMR (CDCl3): δ = 0.47 (s, 9 H), 0.89 (t, J = 7.3 Hz, 9
H), 1.18–1.23 (m, 6 H), 1.29–1.39 (m, 6 H), 1.53–1.61 (m, 6 H),
7.19 (d, J = 4.6 Hz, 1 H), 8.40 (d, J = 4.6 Hz, 1 H) ppm. 13C NMR
(CDCl3): δ = –0.5 (3 C), 10.2 (3 C), 13.8 (3 C), 27.4 (3 C), 29.1 (3
C), 111.3, 126.5, 131.7, 144.9, 149.2, 149.8, 154.6 ppm. MS (EI):
m/z (%) = 458 (100) [M – 57]+, 402 (81), 346 (90), 210 (41), 73 (56).
HRMS (ESI): calcd. for C22H39ClNOSiSn [M + H]+ 516.1503;
found 516.1490.
2-Chloro-7-methylthio-3-(trimethylsilyl)furo[3,2-b]pyridine (3f): The
general procedure was employed by using Me2S2 (301 mg,
3.2 mmol, 4.0 equiv.) as the electrophile. Purification by centrifugal
thin-layer chromatography (cyclohexane/AcOEt, from 10:0 to 95:5)
afforded compound 3f (135 mg, 62%) as a yellow oil. 1H NMR
(CDCl3): δ = 0.45 (s, 9 H), 2.61 (s, 3 H), 6.95 (d, J = 5.25 Hz, 1
H), 8.35 (d, J = 5.25 Hz, 1 H) ppm. 13C NMR (CDCl3): δ = –0.7
(3 C), 14.1, 111.6, 114.1, 114.8, 131.3, 145.8, 149.1, 151.2 ppm. MS
(EI): m/z (%) = 271 (57) [M]+, 256 (100), 236 (55), 73 (59). HRMS
(ESI): calcd. for C11H15ClNOSSi [M + H]+ 272.0327; found
272.0332.
2-Chloro-3,7-bis(trimethylsilyl)furo[3,2-b]pyridine (3a): The general
procedure was employed by using TMSCl (348 mg, 3.2 mmol,
4.0 equiv.) as the electrophile. Purification by centrifugal thin-layer
chromatography (cyclohexane) afforded compound 3a (172 mg,
1
72%) as a white solid; m.p. 42–44 °C. H NMR (CDCl3): δ = 0.41
2-Chloro-7-formyl-3-(trimethylsilyl)furo[3,2-b]pyridine (3g): The ge-
neral procedure was employed by using N,N-dimethylformamide
(s, 9 H), 0.46 (s, 9 H), 7.17 (d, J = 4.7 Hz, 1 H), 8.46 (d, J = 4.7 Hz,
1 H) ppm. 13C NMR (CDCl3): δ = –1.4 (3 C), –0.6 (3 C), 110.9, (DMF, 234 mg, 3.2 mmol, 4.0 equiv.) as the electrophile. Purifica-
123.3, 130.5, 145.0, 149.5, 150.6, 152.4 ppm. MS (EI): m/z (%) =
297 (26) [M]+, 282 (47), 262 (30), 93 (24), 73 (100). HRMS (ESI):
calcd. for C13H21ClNOSi2 [M + H]+ 298.0845; found 298.0851.
tion by centrifugal thin-layer chromatography (cyclohexane/Ac-
OEt, from 10:0 to 95:5) afforded compound 3g (152 mg, 75%) as
1
a white solid; m.p. 73–75 °C. H NMR (CDCl3): δ = 0.47 (s, 9 H),
7230
www.eurjoc.org
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2014, 7226–7231